Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

HKCI:IN

127.75 INR 1.35 1.05%

As of 07:05:55 ET on 06/01/2015.

Snapshot for Hikal Ltd (HKCI)

Open: 129.95 Day's Range: 126.10 - 132.35 Volume: 8,003
Previous Close: 129.10 52wk Range: 88.33 - 167.35 1-Yr Rtn: +44.67%

Stock Chart for HKCI

No chart data available.
  • HKCI:IN 127.75
  • 1D
  • 1M
  • 1Y
129.10
Interactive HKCI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HKCI

Current P/E Ratio (ttm) 25.9654
Estimated P/E(03/2016) -
Relative P/E vs. SENSEX 1.1662
Earnings Per Share (INR) (ttm) 4.9200
Est. EPS (INR) (03/2016) -
Est. PEG Ratio -
Market Cap (M INR) 10,501.11
Shares Outstanding (M) 82.20
30 Day Average Volume 12,478
Price/Book (mrq) 1.9779
Price/Sale (ttm) 1.2035
Dividend Indicated Gross Yield 0.78%
Cash Dividend (INR) 1.0000
Dividend Ex-Date
5 Year Dividend Growth 4.56%
Next Earnings Announcement 05/05/2016
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HKCI

  • Revenue
  • Net Income (M/INR)
  • Profit Margin (%)

Company Profile & Key Executives for HKCI

Hikal Limited specializes in the custom synthesis and contract manufacture of pharmaceuticals, agrochemicals and intermediates. The Group has relationships with a number of companies, including the Sumitomo Corporation, AgrEvo, Merck and Novartis.

Jai V HiremathChairman/Mng Dir/FounderSameer HiremathPresident/Joint Mng Dir
Peter NightingalePresident:R&DSham V WahalekarSenior VP:Finance/Secretary
More Company Profile & Key Executives for HKCI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil